Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure

Journal of Investigative Medicine

Volumn 58, Issue 5, 2010, Pages 707-710

  Gregory, Blake ^a   Larson, Anne M ^a   Reisch, Joan ^a   Lee, William M ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Acetaminophen; Acute liver failure; N acetylcysteine

Indexed keywords

PARACETAMOL;

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; COMA; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; HUMAN; LIVER FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ACETAMINOPHEN; ADOLESCENT; ADULT; ANALGESICS, NON-NARCOTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TEXAS; YOUNG ADULT;

EID: 77954392612     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3181db8764     Document Type: Article

References (28)

1. US Department of Health and Human Services (DHHS). Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Second Laboratory Data File [CD-ROM, series 11, no. 2A]. Hyattsville, MD: Centers for Disease Control and Prevention; 1998.
2. Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: A randomized controlled trial. JAMA. 2006;296:87-93.
3. Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 1995;333: 1118-1127.
4. SchiLdt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg. 1999;5:29-34.
5. Ostapowicz G, Fontana RJ, SchiLdt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947-954.
6. Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis. 2003;23:227-237.
7. O'Grady JG. Acute liver failure. Postgrad Med J. 2005;81:148-154.
8. SchiLdt FV, Lee WM, Bondesen S, et al. Influence of acute and chronic alcohol intake on the clinical course and outcome in acetaminophen overdose. Aliment Pharmacol Ther. 2002;16:707-715.
9. Van Thiel DH, Stauber R, Gavaler JS, et al. Hepatic regeneration. Effects of age, sex hormone status, prolactin, and cyclosporine. Dig Dis Sci. 1991;36:1309-1312.
10. Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003;349: 474-485.
11. Prescott LF, Illingworth RN, Critchley JAJH, et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ. 1979;2:1097-1100.
12. Douglas AP, Hamlyn AN, James O. Controlled trial of cysteamine in treatment of acute paracetamol (acetaminophen) poisoning. Lancet. 1976;1:111-115.
13. Prescott LF, Sutherland GR, Park J, et al. Cysteamine, methionine and penicillamine in the treatment of paracetamol poisoning. Lancet. 1976;2:109-113.
14. Keays R, Harrison PM, Wendon JA, et al. A prospective controlled trial of intravenous N-acetylcysteine in paracetamol-induced fulminant hepatic failure. BMJ. 1991;303:1024-1029.
15. Pauwels A, Mostefa-Kara N, Florent C, et al. Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol. 1993;17:124-127.
16. SchiLdt FV, Bondesen S, Tygstrup N, et al. Prediction of hepatic encephalopathy in paracetamol overdose: A prospective and validated study. Scand J Gastroenterol. 1999;34:723-728.
17. Donaldson BW, Gopinath R, Wanless IR, et al. The role of transjugular liver biopsy in fulminant hepatic failure: relation to other prognostic indicators. Hepatology. 1993;18:1370-1374.
18. Lake J, Sussman N. Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answer. Hepatology. 1995;21:879-882.
19. Shakil AO, Kramer D, Mazariegos GV, et al. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. 2000;6:163-169.
20. Mitchell I, Bihari D, Chang R, et al. Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med. 1998;26:279-284.
21. Takahashi Y, Kumada H, Shimuzu M, et al. A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation. Hepatology. 1994;19:1065-1071.
22. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: An assessment of the King's criteria. J Hepatol. 1997;26:62-68.
23. SchiLdt FV, Ott P, Christensen E, et al. The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage. Clin Pharmacol Ther. 2002;71:221-225.
24. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364-1372.
25. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179-1197.
26. Court MH, Duan SX, Von Moltke LL, et al. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP glucuronosyltransferase isoforms. J Pharmacol Exp Ther. 2001;299:998-1006.
27. Ueshima, Tsutsumi M, Takase S, et al. Acetaminophen metabolism in patients with different cytochrome P4502E1 genotypes. Alcohol Clin Exp Res. 1996;20(suppl 1):25A-28A.
28. Vaquero J, Polson J, Chung C, et al. Infection and the progression to deep hepatic encephalopathy in early fulminant hepatic failure. Gastroenterology. 2003;125:755-764.